ADIPOQ and Insulin resistance: Based on the existing literature linking prenatal PFAS exposure with adverse metabolic profiles, we hypothesized that higher prenatal and mid-childhood plasma PFAS concentrations would be associated with metabolic dysfunction, as manifest by higher leptin, lower adiponectin, and higher homeostatic model assessment of insulin resistance (HOMA-IR), in children.